Connect with us

Research Reports

Gastric Electric Stimulators Market Size Worth US$ 188.4 Mn by 2026 – Future Market Insights

Published

on

Gastric Electric Stimulators Market Size Worth US$ 188.4 Mn by 2026 – Future Market Insights 1

The worldwide uptake of gastric electric stimulators is anticipated to witness hefty demand in 2019, representing a rigorous 6.6% y-o-y growth, while reaching a valuation of approx. US$ 188.4 Mn in 2026. As per Future Market Insights (FMI) report on gastric electric stimulators market for the forecast period 2018–2026, gastric electric stimulators’ demand is anticipated to be accelerated by a host of pacesetters.

The FMI report on gastric electric stimulators market opines that sales of gastric electric stimulators are likely to witness sheer proliferation in coming time, on the back of burgeoning minimally invasive procedures, surging reported cases of gastroparesis, and encouraging reimbursement schemes. Growing pervasiveness of gastroparesis has been identified as the primary demand generating factor making gastric electric stimulators highly preferred treatment substitute for such arduous diseases.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-8992

“Enterra system, a critical medical device which is highly used to treat Gastroparesis has received FDA approval as a humanitarian use device, on the back of its potential to treat or diagnose a disease or condition affecting approx. 4000 individuals annually in the United States. Though conditionally, the American College of Gastroenterology (ACG) also recommends adoption of gastric electric stimulators for individuals with chronic, stubborn nausea and vomiting caused by Gastroparesis. The gastric electric stimulators, like Enterra, is a battery-based gastric neurostimulator, which is usually rooted under the skin in lower abdomen part of the body”, Senior Analyst, FMI.

As per the FMI report on gastric electric stimulators market, considering the rareness of Gastroparesis in tandem with the widespread occurrence of gastric-related issues, investments in R&D and clinical studies have considerably increased in the recent past. Moreover, the growing adoption of gastric electric stimulators as an effective substitute to gastrectomy in patients with end-stage gastric dysfunction, is projected to accelerate the demand for gastric electric stimulators considerably by the end of 2026.

High-Frequency Product Type Gaining Colossal Traction

According to the FMI report, high-frequency variant of gastric electric stimulators are witnessing mammoth traction as being one of the most compelling product type, in comparison to the low-frequency variant of gastric electric stimulators. The FMI gastric electric stimulators market report opines that high-frequency variant of gastric electric stimulators aren’t just minimally invasive and extremely patient-friendly in terms of insertion, but also encompass comparatively longer battery life than the low-frequency variant of gastric electric stimulators. Additionally, as per FMI analysis, with over 75% gastric stimulators market share, high-frequency variant of gastric electric stimulators is likely to ameliorate the Gastroparetic treatment landscape.

Preview Analysis Global Gastric Electric Stimulators Market Segmentation By Product Type (High Frequency GES Devices, Low Frequency GES Devices); By Indication (Gastroparesis, Obesity, Refractory Nausea, Others); By End User (Hospitals, Outpatients Centers): https://www.futuremarketinsights.com/reports/gastric-electric-stimulators-market

Though, gastric electrical stimulation makes the most viable treatment option for chronic drug-refractory nausea and vomiting peripheral to Gastroparesis of idiopathic or diabetic etiology, Enterra Therapy associated risks remain exceptionally high, thereby hampering the adoption of gastric electric stimulators.

North America Gastric Electric Stimulators Market Remains Lucrative

FMI gastric electric stimulators report opines that North America is likely to retain its dominance in the gastric electric stimulators market between 2018 and 2026. According to the FMI report on gastric electric stimulators market, growing investments in medical studies and R&D activities, continuing technical advancements and innovations, coupled with the presence of several leading market players, are other key factors paving way for lucrative opportunities in across North America gastric electric stimulators market.

According to gastric electric stimulators market report, the worldwide gastric electric stimulators market will continue to remain highly consolidated with market Mughals contributing approx. 5o% revenue share to global gastric electric stimulators market, owing to their superior product offering and extensive demographic presence. Further, to capitalize on the growing demand for gastric electric stimulators, leading market players are poised to indulge into collaborations and acquisitions of local players, to reinforce their market presence.

Research Reports

High Preference for Combination Tattoo Removal Lasers, Patients Seek Economic Price & Limited Sessions

Published

on

High Preference for Combination Tattoo Removal Lasers, Patients Seek Economic Price & Limited Sessions 2

According to the latest research by Future Market Insights (FMI), the tattoo removal lasers market closed in on US$ 179 million in 2018. The revenue growth of tattoo removal lasers market has been estimated at a promising rate over the course of coming years. While over 7 in 10 patients prefer aesthetic clinics for the procedure of tattoo removal lasers, market value share of tattoo studios is likely to expand in coming years, as per FMI’s analysis.

Tattoo removal lasers have been incorporating the latest laser technologies specific to tattoo removal procedures. Constant developments in the tattoo removal lasers landscape, increase in product penetration across different regions, and increasing government support for R&D of innovative tattoo removal lasers will remain key demand determinants in tattoo removal lasers market.

Several new technologies have been contributing to the revenue growth of tattoo removal lasers market. However, picosecond tattoo removal lasers are extremely expensive. A combination of wavelengths has been in high demand for tattoo removal. For instance, according to a research study conducted on five patients by the Laser Health Academy, better clearance was achieved with a combination of 1,550 nm non-ablative fractional laser+YAG laser as compared to other tattoo removal lasers. The combination of YAG+YAG also resulted in shorter recovery time.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-2013

According to research studies conducted on tattoo removal lasers, a combination of QS Nd: YAG (1064 nm) and CO2 lasers for tattoo removal also resulted in a significantly high improvement on the combination side for Indian skin. Combination of tattoo removal techniques is being perceived as more effective than only Q-S tattoo removal lasers, as the former reduces the need for multiple sessions.

Moreover, combination tattoo removal lasers have not only reduced the number of sessions required, but also cut costs and reduced adverse effects such as hyper-pigmentation, long-going inflammatory responses, and bulla formation. Extensive research on the efficacy of these combination tattoo removal lasers are warranted, specifically considering the high patient demand for tattoo clearance. Thus, the high demand for combination tattoo removal lasers has consistently driven the tattoo removal lasers market.

However, tattoo removal lasers work differently on different skin types, which may involve multiple adverse effects. Tattoo removal lasers that involve Q-switched also require eye protection for the prevention of retinal damage. Q-switched ruby tattoo removal lasers are linked with high clearance rates but are also contradictory because of the high incidence of prolonged hypopigmentation. Such adverse effects of tattoo removal lasers will remain are expected to hamper the growth of the tattoo removal lasers market during the forecast period.

Preview Analysis Global Tattoo Removal Lasers Market Segmentation  By Product Type (Q-Switched Laser, Picosecond Laser, Combination Laser); By End Use (Aesthetic Clinics, Tattoo Studios): https://www.futuremarketinsights.com/reports/tattoo-removal-lasers-market

The tattoo removal lasers market report tracks some of the key companies operating in the tattoo removal lasers market, which include Hologic Inc. (Cynosure), Shanghai Fosun Pharmaceutical(Group)Co., Ltd. (Alma Lasers), Cutera,  Syneron® Medical Ltd., Fotona d.o.o., LUTRONIC, Lumenis, El.En. S.p.A. (Asclepion Laser Technologies GmbH), and Lynton Lasers.

Some of the commonplace complications that result post tattoo removal lasers treatment include prolonged erythema, hyperpigmentation, hypertrophic scar formation, and disseminated infection. On the other side, complications associated with fractional lasers include transient pigmentary changes, mild fibrosis, and hypopigmentation. Though most of the adverse effects associated with tattoo removal lasers can be cured within a short span of time, some of them may lead to serious complications in terms of skin texture and pigmentation.

Continue Reading

Research Reports

Global Demand for Weight Loss & Obesity Management Receiving Strong Impetus from Spectacular Expansion of Medical Tourism Sector across Asia

Published

on

Global Demand for Weight Loss & Obesity Management Receiving Strong Impetus from Spectacular Expansion of Medical Tourism Sector across Asia 3

The growth of weight loss and obesity management market is attributed to the rising epidemic of obesity across the globe. According to the latest research by Future Market Insights (FMI), the global weight loss and obesity management market is anticipated to reach a valuation of over US$ 4.9 Bn, by the end of 2028. The weight loss and obesity management market is expected to expand at a steady CAGR of 5.2%, over the forecast period of 2018-2028.

Developing Regions More Prone to Obesity & Other Comorbidities

Increasing number of cases of obesity and related comorbidities will lead to the growing adoption of drugs and devices for weight loss and obesity management, which will further fuel the growth of the global weight loss and obesity management market during the forecast period.

The weight loss and obesity management market is majorly driven by the rising prevalence of obesity. The rising epidemic of obesity presents a major challenge to disease prevention across the globe. It is estimated that by 2030, 38% of the world’s adult population will be overweight and around 20% will be obese. This obesity epidemic is more prevalent in the Middle East and the Asia Pacific regions where food import is quite high. Weight loss and obesity management are helpful in the treatment of highly critical obesity and comorbidities associated with it, such as diabetes, asthma, sleep apnea, and hypertension, etc.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-411

Increasing health consciousness is also cited as an important factor boosting the revenue growth of the global weight loss and obesity management market. Sizeable consumer population in developed regional markets will particularly continue to generate high demand for weight loss and obesity management practices, according to the report. Millennial and Generation-X consumers are gradually adopting advanced aesthetic services, including weight loss and obesity management, thereby creating adequate opportunities for manufacturers of weight loss and obesity management drugs and devices.

Key Vendors Targeting Extension of Product Portfolio

Leading companies operating in weight loss and obesity management market are majorly focusing on strengthening their product portfolio. Product line extensions help companies to launch newer products with unique features for specific indications. This results in an increased market share of companies in the highly competitive weight loss and obesity management market. In response to increasing demand from various healthcare professionals to effectively treat obesity with minimum long-term side effects, manufacturers are focusing on developing innovative and specific products.

Product innovation is expected to boost revenue and volume growth of the weight loss and obesity management market during the forecast period. For instance, an additional FDA patents approval for VIVUS, Inc.’s Qsymia, for the covering compositions of Qsymia and covering methods for effecting weight loss using Qsymia (phentermine and topiramate).

Preview Analysis Global Weight Loss and Obesity Management Market Segmented By Product type (drugs, devices); By distribution sales (institutional sales, retail sales): https://www.futuremarketinsights.com/reports/weight-loss-and-obesity-management-market

However, the high cost involved in research and development of obesity drugs is a great challenge for the growth of the weight loss and obesity management market. Additionally, long gestation time required for research and developmental activities as well as the need for a number of essential clinical trials to test drugs adds up to significant expenditure. The limitations posed by high development cost of anti-obesity drugs might hinder the growth of the global weight loss and obesity management market. Moreover, the high cost of surgical procedures, such as gastric bypass surgery, adjustable gastric banding, gastric sleeve surgery and gastric balloon treatment, may also affect the growth of the global weight loss and obesity management market adversely.

The global weight loss and obesity management market is estimated based on product type, and distribution sales. Based on product type, the weight loss and obesity management market has been segmented into drugs and devices.

Drugs product type segment is further segmented into GLP-1 receptor agonists, lipase inhibitors, serotonin receptor agonist, a combination drug, and others. Devices product type segment is further segmented into liposuction devices, bariatric stapling devices, gastric band, gastric balloon systems, gastric emptying systems, and gastric electrical stimulation systems.

Devices segment is expected to hold maximum market share in the global weight loss and obesity management market. Based on distribution sales, the weight loss and obesity management market has been segmented into institutional sales and retail sales. In terms of revenue, institutional sales dominated the global weight loss and obesity management market in 2017.

Continue Reading

Research Reports

FMI’s Study on Benign Prostatic Hyperplasia Prostate Treatment Market: Least Invasive Alternatives in Trend

Published

on

FMI’s Study on Benign Prostatic Hyperplasia Prostate Treatment Market: Least Invasive Alternatives in Trend 4

The approximately US$ 25 Bn market for benign prostatic hyperplasia prostate treatment is likely to expand at 4.6% CAGR during 2018-2028, according to a recent research report of Future Market Insights (FMI). The report has envisaged steady growth prospects for the revenue of global benign prostatic hyperplasia prostate treatment market through 2028.

The World Population Prospects’ data (2017) projected that the number of individuals aged 60 years and above will double by 2050, and triple by 2100. With such a high pace estimated for the growth of population aged 60 years and above, it is more likely that the prevalence of aging related health conditions will also increase at a considerable pace in the years to come. A high prevalence rate of benign prostatic hyperplasia (BPH) in men, the demand for improved and more effective treatment options continues to increase at a high rate.

Alpha-blockers & Drugs for Lower UTIs Remain Pivotal in Benign Prostatic Hyperplasia Prostate Treatment

The drug treatment has been vital in treating benign prostatic hyperplasia conditions and lower UTIs, which has been attributed to widespread availability of drug-based benign prostatic hyperplasia prostate treatment. This factor, in particular, will play an instrumental role in driving the growth of the benign prostatic hyperplasia prostate treatment market during the forecast period. Drugs will remain the first choice of treatment for benign prostatic hyperplasia.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-1664

Benign prostatic hyperplasia increases the risk of other disorders as well. The most common disorder caused due to benign prostatic hyperplasia is lower UTI (urinary tract infection) for which, Alpha-blockers constitute the first line of treatment. However, other drugs are also available in the market, which offer relief from the benign prostatic hyperplasia symptoms. Other drugs include alpha reductase inhibitors, phosphodiesterase-5 (PDE-5) inhibitors, muscarinic receptor antagonists, and combination drugs.

Demand for Benign Prostatic Hyperplasia Prostate Treatment Higher in Developed Regions, Patient Pool Expanding Steadily in Developing Markets

Owing to significantly growing prevalence of benign prostatic hyperplasia in North American men, benign prostatic hyperplasia prostate treatment market is expected to witness strong growth within the region, followed by Europe.

Extensive availability of benign prostatic hyperplasia prostate treatments, increasing clinical trials, improving R&D scenario, higher healthcare spending, and favorable government initiatives will continue to assist the growth of the benign prostatic hyperplasia prostate treatment market in developed regions.

On the other side, Asia Pacific’s benign prostatic hyperplasia prostate treatment market is foreseen to witness significant growth, owing to steadily expanding patient pool due in the region.

Preview Analysis Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market Segmented By Treatment Type (drugs(alpha-blockers, alpha reductase inhibitors, phosphodiesterase-5 (PDE-5) inhibitors, muscarinic receptor antagonists, and combination drugs), devices (prostatic stents, suture base implant systems, and transurethral RF thermal therapy)); By Distribution Channel (Institutional sales (hospitals, ambulatory surgical centers, and specialty clinics), retail sales (retail pharmacies and drug stores), and online pharmacies) : https://www.futuremarketinsights.com/reports/benign-prostatic-hyperplasia-bph-and-prostate-treatment-market

UroLift System to Revolutionize the Competitive Landscape of Benign Prostatic Hyperplasia Prostate Treatment Market

Teleflex Incorporated’s NeoTract recently launched UroLift® System as a highly effective, least invasive option for benign prostatic hyperplasia prostate treatment. The UroLift® System is permanently implanted via a transurethral outpatient procedure and predominantly relieves prostate obstruction, which is one of the primary symptoms of benign prostatic hyperplasia. The company has also declared insurance coverage for UroLift® System. While the coverage is being provided by Humana, it is most likely to improve awareness about increasing availability and broadening access of minimally invasive treatment methods in urological conditions such as benign prostatic hyperplasia. This in turn will encourage adoption of UroLift® System among patients seeking effective benign prostatic hyperplasia prostate treatment.

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.

Call For Entries

Global Banking and Finance Review Awards Nominations 2021
2021 Awards now open. Click Here to Nominate

Latest Articles

Gastric Electric Stimulators Market Size Worth US$ 188.4 Mn by 2026 – Future Market Insights 5 Gastric Electric Stimulators Market Size Worth US$ 188.4 Mn by 2026 – Future Market Insights 6
Research Reports13 seconds ago

Gastric Electric Stimulators Market Size Worth US$ 188.4 Mn by 2026 – Future Market Insights

The worldwide uptake of gastric electric stimulators is anticipated to witness hefty demand in 2019, representing a rigorous 6.6% y-o-y...

High Preference for Combination Tattoo Removal Lasers, Patients Seek Economic Price & Limited Sessions 7 High Preference for Combination Tattoo Removal Lasers, Patients Seek Economic Price & Limited Sessions 8
Research Reports1 min ago

High Preference for Combination Tattoo Removal Lasers, Patients Seek Economic Price & Limited Sessions

According to the latest research by Future Market Insights (FMI), the tattoo removal lasers market closed in on US$ 179 million in...

Global Demand for Weight Loss & Obesity Management Receiving Strong Impetus from Spectacular Expansion of Medical Tourism Sector across Asia 9 Global Demand for Weight Loss & Obesity Management Receiving Strong Impetus from Spectacular Expansion of Medical Tourism Sector across Asia 10
Research Reports2 mins ago

Global Demand for Weight Loss & Obesity Management Receiving Strong Impetus from Spectacular Expansion of Medical Tourism Sector across Asia

The growth of weight loss and obesity management market is attributed to the rising epidemic of obesity across the globe....

FMI’s Study on Benign Prostatic Hyperplasia Prostate Treatment Market: Least Invasive Alternatives in Trend 11 FMI’s Study on Benign Prostatic Hyperplasia Prostate Treatment Market: Least Invasive Alternatives in Trend 12
Research Reports3 mins ago

FMI’s Study on Benign Prostatic Hyperplasia Prostate Treatment Market: Least Invasive Alternatives in Trend

The approximately US$ 25 Bn market for benign prostatic hyperplasia prostate treatment is likely to expand at 4.6% CAGR during...

Global Motorcycle Start Stop Systems Market 2021 Growth, COVID Impact, Trends Analysis Report 2027 13 Global Motorcycle Start Stop Systems Market 2021 Growth, COVID Impact, Trends Analysis Report 2027 14
Research Reports4 mins ago

Global Motorcycle Start Stop Systems Market 2021 Growth, COVID Impact, Trends Analysis Report 2027

Future Market Insights has adopted multi-disciplinary approach to shed light on the evolution of the Motorcycle Start Stop Systems Market during the...

Urology Imaging Systems Market to Record an Exponential CAGR of 3.8% by 2028- Future Market Insights 15 Urology Imaging Systems Market to Record an Exponential CAGR of 3.8% by 2028- Future Market Insights 16
Research Reports5 mins ago

Urology Imaging Systems Market to Record an Exponential CAGR of 3.8% by 2028- Future Market Insights

According to the latest research by the FMI, the global urology imaging systems market is expected to account for over US$ 486.4...

Marine Ventilation Systems Market Share, Global Industry Size, Growth, SWOT Analysis, Top Companies, Competitor Landscape, Regional Outlook 2027 17 Marine Ventilation Systems Market Share, Global Industry Size, Growth, SWOT Analysis, Top Companies, Competitor Landscape, Regional Outlook 2027 18
Research Reports6 mins ago

Marine Ventilation Systems Market Share, Global Industry Size, Growth, SWOT Analysis, Top Companies, Competitor Landscape, Regional Outlook 2027

Future Market Insights has adopted multi-disciplinary approach to shed light on the evolution of the Marine Ventilation Systems Market during the historical...

Hematology Diagnostics Market Players Eye Strategic Partnerships to Vie with More Diverse Portfolios, finds FMI Study 19 Hematology Diagnostics Market Players Eye Strategic Partnerships to Vie with More Diverse Portfolios, finds FMI Study 20
Research Reports7 mins ago

Hematology Diagnostics Market Players Eye Strategic Partnerships to Vie with More Diverse Portfolios, finds FMI Study

The hematology diagnostics market has witnessed the advent of a wide range of hematology testing solutions that combine the attributes...

Global Marine Fasteners Market: Things to Focus on to Ensure Long-term Success| Key Players include Attwood Marine Products, SEASTAR SOLUTIONS, Marine Fasteners, Inc., Fasco Fasteners 21 Global Marine Fasteners Market: Things to Focus on to Ensure Long-term Success| Key Players include Attwood Marine Products, SEASTAR SOLUTIONS, Marine Fasteners, Inc., Fasco Fasteners 22
Research Reports8 mins ago

Global Marine Fasteners Market: Things to Focus on to Ensure Long-term Success| Key Players include Attwood Marine Products, SEASTAR SOLUTIONS, Marine Fasteners, Inc., Fasco Fasteners

Future Market Insights has adopted multi-disciplinary approach to shed light on the evolution of the Marine Fasteners Market during the historical period....

The US$ 85 million Market for Loop-mediated Isothermal Amplification (LAMP) to Shape the Future of Molecular Diagnostics – Future Market Insights 23 The US$ 85 million Market for Loop-mediated Isothermal Amplification (LAMP) to Shape the Future of Molecular Diagnostics – Future Market Insights 24
Research Reports9 mins ago

The US$ 85 million Market for Loop-mediated Isothermal Amplification (LAMP) to Shape the Future of Molecular Diagnostics – Future Market Insights

Global demand for loop-mediated isothermal amplification technology reached around US$ 85 million in 2018, as indicated by a new research...

Newsletters with Secrets & Analysis. Subscribe Now